Search Results - "Janus"

Potential Link Between Janus Kinase 2 Mutation and Renal Artery Stenosis Leading to Refractory Secondary Hypertension - A Case Report by Lakshmipriya V, Vanishree Murugavel, Jayaganesh

Connect to this object online.

Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis by Farnam B. Sedeh, Mattias A.S. Henning, Gregor B.E. Jemec, Kristina S. Ibler

Connect to this object online.

Fournier's gangrene that initially mimicked pubic cellulitis in an elderly woman administered a Janus kinase inhibitor, methotrexate, and prednisolone for rheumatoid arthritis by Takahiro Shiratori, Naoki Oiso, Kohei Yamauchi, Akira Kawada

Connect to this object online.

Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study by Ida Vittrup, David Thein, Simon Francis Thomsen, Alexander Egeberg, Jacob P. Thyssen

Connect to this object online.

Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews by Yun-Kyoung Song, Junu Song, Kyungim Kim, Kyungim Kim, Jin-Won Kwon

Connect to this object online.

Total colonic aganglionosis and cleft palate in a newborn with Janus-cysteine 618 mutation of RET proto-oncogene: a case report by Ingrid Anne Mandy Schierz, Marcello Cimador, Mario Giuffrè, Claudia Maria Aiello, Vincenzo Antona, Giovanni Corsello, Ettore Piro

Connect to this object online.

Google Search Trends About Systemic Psoriasis Treatment: What Do People Want to Know About Biologics and Janus Kinase Inhibitors? by Subin Lim, Sarah Kooper-Johnson, Courtney A Chau, Claire Chen, Fei-Shiuann Clarissa Yang, Gabriela Cobos

Connect to this object online.

Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore by Yik Weng Yew, MBBS, MPH, PhD, Pei Ming Yeo, MBBS, MRCP

Connect to this object online.

Development of a Formulation and In Vitro Evaluation of a Pulmonary Drug Delivery System for a Novel Janus Kinase (JAK) Inhibitor, CPL409116 by Aleksandra Rzewińska, Jakub Szlęk, Damian Dąbrowski, Ewelina Juszczyk, Katarzyna Mróz, Heikki Räikkönen, Mia Siven, Maciej Wieczorek, Przemysław Dorożyński

Connect to this object online.

More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review's Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis by Paul Langley

Connect to this object online.

Kinetic‐Pharmacodynamic Model of Platelet Time Course in Patients With Moderate‐to‐Severe Atopic Dermatitis Treated With Oral Janus Kinase 1 Inhibitor Abrocitinib by Elena Soto, Christopher Banfield, Pankaj Gupta, Mark C. Peterson

Connect to this object online.

Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology by Gaudet Daniel, Simard Raynald, Paradis François W

Connect to this object online.

Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study by Masahiko Miyashiro, Teita Asano, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu, Junya Masuda

Connect to this object online.

Detection of the Janus kinase 2 V617F mutation using a locked nucleic-acid, real-time polymerase chain reaction assay by Tshiphiri Senamela, Marleen Kock, Piet Becker, Joachim J.C. Potgieter

Connect to this object online.

The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database by Tae Maeshima, Sayaka Aisu, Naoki Ohkura, Machiko Watanabe, Fumio Itagaki

Connect to this object online.

Biotechnologically Produced Lavandula angustifolia Mill. Extract Rich in Rosmarinic Acid Resolves Psoriasis-Related Inflammation Through Janus Kinase/Signal Transducer and Activator of Transcription Signaling by Ivanka K. Koycheva, Ivanka K. Koycheva, Liliya V. Vasileva, Kristiana M. Amirova, Kristiana M. Amirova, Andrey S. Marchev, Andrey S. Marchev, Zhivka P. Balcheva-Sivenova, Zhivka P. Balcheva-Sivenova, Milen I. Georgiev, Milen I. Georgiev

Connect to this object online.

Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy by Bao-Xin Ma, MD, Jie Li, MD, Hua Li, MD, Sui-Sheng Wu, MD

Connect to this object online.

Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids by Juncheng Lu, Elena N. Atochina-Vasserman, Devendra S. Maurya, Muhammad Irhash Shalihin, Dapeng Zhang, Srijay S. Chenna, Jasper Adamson, Matthew Liu, Habib Ur Rehman Shah, Honey Shah, Qi Xiao, Bryn Queeley, Nathan A. Ona, Erin K. Reagan, Houping Ni, Dipankar Sahoo, Mihai Peterca, Drew Weissman, Virgil Percec

Connect to this object online.

Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials by Tatjana Welzel, Carolyn Winskill, Nancy Zhang, Andreas Woerner, Marc Pfister

Connect to this object online.

Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study by Yun-Kyoung Song, Gaeun Lee, Jinseub Hwang, Ji-Won Kim, Jin-Won Kwon

Connect to this object online.